Andrea van Elsas is a Partner at Third Rock Ventures where they invest in life sciences/biotech, primarily at the Series A stage across the United States and Europe/EMEA. They serve on the boards of Celsius Therapeutics, Lava Therapeutics (Scientific Advisory Board Chair), Mendus AB (Supervisory Board), and InteRNA Technologies (Supervisory Board/SAB), and have invested in companies including Clasp Therapeutics, Abata Therapeutics, Lava Therapeutics, and Celsius Therapeutics. Before Third Rock Ventures, Andrea was Chief Scientific Officer at Aduro Biotech, Abata Therapeutics, and Clasp Therapeutics; an Operational Partner at Gilde Healthcare; VP of Research at AM-Pharma; and held director-level roles in tumor immunology at Organon (1999–2011). Andrea studied at Leiden University and the University of Amsterdam, and lives in Berkeley, California.
Andrea van Elsas, Partner @ Third Rock. Profile with intro opportunities and ranking information.
Not Yet Mapped
We've created a profile for Andrea van Elsas from . Our ranking analysis and additional data will be available once our research is complete.
Rankings and detailed information coming soon
Network Strength
No ranking data available yet.
How to get an intro to Andrea
Map your path to Andrea instantly
Connect your network and Draftboard will automatically find and score the strongest paths to Andrea
That's it. Draftboard does the rest.
Rankings based on connection strength analysis - we ONLY show aggregate data, never specific connection data.